Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Mar 4;194:245–251. doi: 10.1016/j.puhe.2021.02.025

Vaccine hesitancy in the era of COVID-19

G Troiano 1,, A Nardi 1
PMCID: PMC7931735  PMID: 33965796

Abstract

Objectives

In 2019, a new coronavirus has been identified and many efforts have been directed toward the development of effective vaccines. However, the willingness for vaccination is deeply influenced by several factors. So the aim of our review was to analyze the theme of vaccine hesitancy during COVID-19 pandemic, with a particular focus on vaccine hesitancy toward COVID-19 vaccine.

Study design

Narrative review.

Methods

In November 2020, we performed a search for original peer-reviewed articles in the electronic database PubMed (MEDLINE). The key search terms were “Vaccine hesitancy AND COVID-19”. We searched for studies published during COVID-19 pandemic and reporting information about the phenomenon of vaccine hesitancy.

Results

Fifteen studies were included in the review. The percentage of COVID-19 vaccine acceptance was not so high (up to 86.1% students or 77.6% general population); for influenza vaccine, the maximum percentage was 69%. Several factors influenced the acceptance or refusal (ethnicity, working status, religiosity, politics, gender, age, education, income, etc.).

The most given reasons to refuse vaccine were as follows: being against vaccines in general, concerns about safety/thinking that a vaccine produced in a rush is too dangerous, considering the vaccine useless because of the harmless nature of COVID-19, general lack of trust, doubts about the efficiency of the vaccine, belief to be already immunized, doubt about the provenience of vaccine.

Conclusions

The high vaccine hesitancy, also during COVID-19 pandemic, represents an important problem, and further efforts should be done to support people and give them correct information about vaccines.

Keywords: Vaccine hesitancy, COVID-19, Pandemic, Influenza, Review

Introduction

The World Health Organization (WHO) defined the vaccine hesitancy as a behavior, influenced by a number of factors including issues of confidence (do not trust vaccine or provider), complacency (do not perceive a need for a vaccine, do not value the vaccine), and convenience (access). Vaccine-hesitant individuals are a heterogeneous group who hold varying degrees of indecision about specific vaccines or vaccination in general. Vaccine-hesitant individuals may accept all vaccines but remain concerned about vaccines, some may refuse or delay some vaccines but accept others; some individuals may refuse all vaccines.1

In December 2019, a cluster of patients presented with pneumonia caused by an unknown pathogen that was linked to the seafood wholesale market in Wuhan, China. Subsequently, a new coronavirus was identified by sequencing the whole genome of patient samples.2 It was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the Coronavirus Study Group of the International Committee on Taxonomy of Viruses,3 and the disease caused by the virus was named coronavirus disease 2019 (COVID-19) by the WHO.

After infecting and causing the death of thousands of persons in China, the virus has spread, reaching Italy and other European countries and the USA, with the number of confirmed new cases currently increasing every day.4 The WHO declared it a pandemic due to the widespread infectivity and high contagion rate.

Many efforts have been directed toward the development of vaccines against COVID-19 to avert the pandemic and most of the developing vaccine candidates have been using the S-protein of SARS-CoV-2.5

Currently, three vaccines are authorized and recommended to prevent COVID-19. Large-scale (phase 3) clinical trials are also in progress or being planned for other COVID-19 vaccines in the United States.6 , 7

The presence of available vaccines is the key element to minimize new infections, so it is crucial to vaccinate people, and especially healthcare workers.8

However, the willingness for vaccination is deeply influenced especially by the mistrust of health authorities, as demonstrated in other studies focused on vaccine trials of HPV and HIV, in Europe and United States.9 , 10

The worldwide COVID-19 crisis may have a more or less important impact on public trust in public health authorities, science, and medicine, from a country to another, as per the burden of its health and socioeconomic consequences and intensity of controversies.11

In addition to a segment of population that refuses vaccines, the novelty of the disease and concerns over safety and efficacy of the vaccine have generated a sizable proportion of US people indicating reluctance to getting vaccinated against COVID-19.12

But this phenomenon is also spread elsewhere: in May 2020, about 25% of people in 5 surveys in France (representative samples of 1000 adults) stated that they would refuse a future vaccine against it if it would have been available, mainly due to safety concerns around a vaccine developed in an emergency situation.13

The aim of our study was, therefore, through a narrative review, to deepen and analyze the theme of vaccine hesitancy during COVID-19 pandemic, with a particular focus on vaccine hesitancy toward the COVID-19 vaccine.

Methods

Search strategy

In November 2020 (the search was performed on November 3rd), we performed a search for original peer-reviewed articles in the electronic database PubMed (MEDLINE). The key search terms were “Vaccine hesitancy AND COVID-19”. We searched for studies published during COVID-19 pandemic (up to November 2020) and reporting information about the phenomenon of vaccine hesitancy.

Inclusion criteria

We considered eligible for the review all the articles (original articles, but also letters to the editor if containing original data) that reported data on i) type of investigated vaccine (COVID-19 vaccine but also other vaccines if investigated), ii) a deep and complete analysis of the attitude toward the vaccine and the main reasons or factor influencing this attitude. We considered eligible for the review all descriptive studies, written in English, French, Spanish, Italian.

Study selection and data extraction

Studies were selected in a 2-stage process. Titles and abstracts from electronic searches were scrutinized by 2 reviewers independently (A.N. and G.T.) and full manuscripts and their citations list were analyzed to retrieve missing articles and to select the eligible manuscripts as per the inclusion criteria. The level of agreement between the reviewers was high. Then, each article was further reviewed to identify the manuscripts suitable for our review.

Results

The literature search yielded 49 publications. The titles, abstracts, and full texts of these manuscripts were screened, resulting in 15 studies considered potentially eligible to be included in the review (4 articles were letters without original data, 1 was a review, 29 were not in line with the aim of the study).8 , 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26

The studies, published in 2020, have been conducted in the period March–September 2020; they involved a minimum of 316 (Pogue et al.) and a maximum of 5024 (Salali et al.) participants. Studies have been conducted in several countries: USA, UK, Turkey, France, Malta, Italy, Hong Kong, Israel, Canada, Japan, Spain, Switzerland involving a variegate typology of participants (most of them were focused on general population adult or not, others specifically on some categories, e.g., students, parents, healthcare workers). Two vaccines have been analyzed: COVID-19 vaccine has been investigated by most of authors (except for Goldman et al. who focused only on influenza); influenza vaccine has been investigated also by Grech et al. and by Wang et al. The principal results of our review are shown in Table 1 .

Table 1.

Main characteristics of the studies included in the review (n/r = not reported or not explicitly reported).

Author, year Setting Period of study Method Inclusion criteria Participants Investigated vaccine Sociodemographic characteristics Attitude toward vaccination
Olagoke, 2020 USA 22 March 2020 Survey
  • -

    >18 years old

  • -

    Living in USA

501 COVID-19
  • -

    Mean age 32.44 (SD 11.94) years

  • -

    Females 55.29%

  • -

    White 53.71%

  • -

    Employed 53.71%

  • -

    Black/African, unemployed, and with personal belief against vaccines had lower COVID-19 vaccination intention

  • -

    Religiosity was negatively correlated with COVID-19 vaccination

Kreps, 2020 USA 9 July 2020 Questionnaire
  • -

    US adults

1971 2 Hypothetical COVID-19 vaccinesa
  • -

    Median age 43 years (range 30–58)

  • -

    Females 51%

  • -

    White 73%

  • -

    56% participants declared to choose the presented vaccine

  • -

    A greater vaccine efficacy, a longer protection duration and a lower incidence of side effects were associated to a higher probability of choosing a vaccine

  • -

    Respondents were less likely to choose vaccines developed outside of the United States, particularly from China

  • -

    Respondents who declared Democratic political partisanship were significantly more likely to choose to receive vaccination

  • -

    Women, black, low education, and low age were associated to a lower willingness to receive vaccination

Salali, 2020 UK and Turkey May 2020 Survey
  • -

    >18 years old

  • -

    Living in UK or Turkey

  • -

    1088 in UK

  • -

    3936 in Turkey

COVID-19 n/r
  • -

    31% (Turkey) and 14% (UK) were unsure to be vaccinated

  • -

    3% in both countries refused to be vaccinated

  • -

    Acceptance was higher among those who believed the natural origin of pandemics, among those who had higher anxiety related to COVID-19

  • -

    Men were more likely to accept vaccines

  • -

    Have a graduate degree and children decreased the odds of vaccine acceptance in Turkey, but not in UK

Ward, 2020 France April 2020 Cross-sectional online survey n/r 5018 COVID-19
  • -

    <35 years old (N = 1290)

  • -

    35–64 years old (N = 2494)

  • -

    >64 years old (N = 1234)

  • -

    Females (N02629)

  • -

    Males (N = 2389)

  • -

    Women, young people (<35 years old) and those with a lower income were more likely to refuse vaccines

  • -

    No difference was observed between those who were diagnosed with COVID-19 and those who were not

  • -

    Those who were highly concerned about being infected were less likely to refuse the vaccine

  • -

    Those who felt close to radical parties or those who did not vote/did not feel close to any party were significantly more likely to refuse the vaccine

  • -

    Most given reasons to refuse vaccine were: being against vaccines in general (27.6%), thinking that a vaccine produced in a rush is too dangerous (64.4%), considering the vaccine useless because of the harmless nature of COVID-19 (9.6%). Other respondents refused vaccine because of a general lack of trust, doubts about the efficiency of the vaccine or belief to be already immunized

Pogue, 2020 USA n/r Survey n/r 316 COVID-19
  • -

    <18 years old 2.16%

  • -

    18–25 years old 12.45%

  • -

    26–35 years old 18.21%

  • -

    36–45 years old 31.48%

  • -

    46–55 years old 3.4%

  • -

    >55 years old 32.41%

  • -

    Females 49.38%

  • -

    White 63.27%

  • -

    Respondents routinely vaccinated were more likely to receive COVID-19 vaccine

  • -

    Respondents who had a greater perceived impact of COVID-19 in America were more likely to receive COVID-19 vaccine

  • -

    Income and political ideology had no relationship with the attitude toward vaccination

  • -

    68.57% of respondents indicated they were amenable to receive the vaccine

  • -

    15.89% neither agreed or disagreed

  • -

    The main reasons to refuse vaccine were: concerns about safety (45.45%) and lack of trust in the source (13.54%) and other reasons (15.45% – above all more testing before accepting vaccine)

Graffigna, 2020 Italy Early days of the so-called phase 2 Survey
  • -

    Italian adult citizens

1004 COVID-19
  • -

    18–38 years old 34.4%

  • -

    39–52 years old 33.6%

  • -

    >52 years old 32.1%

  • -

    Females 50.9%

  • -

    58.6% of respondents indicated they agreed to receive the vaccine

  • -

    15.4% disagreed

  • -

    26.2% were uncertain about receiving the vaccine

  • -

    Respondents with a general positive attitude toward vaccine were more likely to receive COVID-19 vaccine

  • -

    There was a positive relationship between health engagement and willingness to vaccinate

Detoc, 2020 France 26 March 2020–20 April 2020 Survey n/r 3259 COVID-19
  • -

    <30 years old 20.6%

  • -

    30–49 years old 46.11%

  • -

    50–64 years old 24.6%

  • -

    65–80 years old 8.3%

  • -

    >80 years old 0.4%

  • -

    Females 67.4%

  • -

    24.1% had chronic medical conditions

  • -

    Vaccine hesitancy 35.3%

  • -

    77.6% will certainly or probably be vaccinated against COVID-19

  • -

    83.1% men and 74.2% women were COVID-19 vaccine acceptors (P < 0.05)

  • -

    81.5% healthcare workers and 73.7 non-healthcare workers were COVID-19 vaccine acceptors (P < 0.05)

  • -

    Older age, male gender, fear about COVID-19, be healthcare workers and individual perceived risk were associated with COVID-19 vaccine acceptance

Fisher, 2020 USA 16–20 April 2020 Survey
  • -

    Adults

991 COVID-19
  • -

    18–29 years old 20.4%

  • -

    30–44 years old 25%

  • -

    45–59 years old 24.6%

  • -

    >60 years old 30%

  • -

    Females 51.5%

  • -

    White 63.3%

  • -

    57.6% participants intended to be vaccinated

  • -

    31.6% were not sure

  • -

    10.8% did not intend to be vaccinated

  • -

    Females, young, black/hispanic, those with a lower education and income, those who did not receive influenza vaccine were less likely to have intention to accept vaccination

  • -

    The main reasons to refuse vaccine were: concerns about the vaccine, need additional information, anti-vaccine attitude, low trust in vaccine development

Palamenghi, 2020 Italy Phase 1 (early days after initial spread of SARS-COV-2) and Phase 2 (early days after the Italian reopening after lockdown) Survey
  • -

    Italian citizens

968 (phase 1)
1004 (phase 2)
COVID-19 n/r
  • -

    59% of participants intended to be vaccinated (Phase 2)

  • -

    Decrease in trust toward scientific research, and vaccines' efficacy

  • -

    Middle age group had a reduced willingness to be vaccinated compared with 18–34 years old people and over 60 years old people.

Dror, 2020 Israel March 2020 Survey
  • -

    Healthcare personnel or general population

1941 COVID-19 n/r
  • -

    No difference in vaccine acceptance among healthcare personnel or not

  • -

    Males, those who perceived themselves at higher risk of infection, people currently vaccinated against influenza had a higher acceptance

  • -

    The rate of acceptance of COVID-19 vaccine was lower than the acceptance of Influenza vaccine among healthcare workers

Barello, 2020 Italy n/r Cross-sectional study
  • -

    Students

934 COVID-19
  • -

    Mean age 23.6 (SD 4.9) years old

  • -

    Females 79.6%

  • -

    86.1% chose to be vaccinated

  • -

    13.9% refused to be vaccinated

  • -

    No significant differences were observed for socio-demographic characteristics or for type of study (healthcare students or not)

COCONEL Group, 2020 France 27–29 March 2020 Online survey
  • -

    French population over 18 years old

1012 COVID-19 n/r
  • -

    26% refused to be vaccinated

  • -

    Refusals were higher among low-income people, young women and older than 75 years old

  • -

    Those who voted for far left or far right candidate in the last elections were more likely to refuse vaccination

Grech, 2020 Malta 11–16 September 2020 Questionnaire
  • -

    Healthcare workers

1002 COVID-19 and influenza n/r Influenza:
  • -

    Significant increase in willingness to be vaccinated (from 49% to 69%)

COVID-19
  • -

    Almost 50% expressed their willingness to be vaccinated

  • -

    Almost 25% were undecided and almost 25% did not want to be vaccinated

  • -

    Men were more likely to accept vaccine

Wang, 2020 Hong Kong 26 February – 31 March 2020 Survey
  • -

    Nurses (not retired or working in administrative or academic positions)

806 COVID-19 and Influenza
  • -

    18–29 years old 22.7%

  • -

    30–39 years old 36%

  • -

    40–49 years old 24.2%

  • -

    >50 years old 17.1%

  • -

    Females 80.8%

  • -

    25.8% had chronic medical conditions

Influenza:
  • -

    Similar acceptance rate between 2019 and 2020 (47.5% and 44.7% respectively)

COVID-19
  • -

    40% nurses had intention to accept COVID-19 vaccination

  • -

    Males, those with chronic diseases, or those who accepted the seasonal influenza vaccine in 2019 were more likely to have intention to accept COVID-19 vaccination

  • -

    The main reasons to refuse vaccine were: suspicion on efficacy, effectiveness, safety (76.43%); believing vaccination is not necessary (18.05%)

Goldman, 2020 USA, Canada, Israel, Japan, Spain, Switzerland 27 march 2020–30 June 2020 Survey
  • -

    Parents or caregivers of patients older than 1 year and younger than 19 years old

2422 Influenza
  • -

    274 (26.7%) +102 (24.4%) fathersb

  • -

    723 (70.5%)+299 (71.5%) mothersb

  • -

    Mean age 40.7

  • -

    54.3% intended to vaccinate their children (+15.9% compared to the past 12 months)

  • -

    58.3% intended to receive a vaccine for themselves

  • -

    1025 had no intention to vaccinate their children

  • -

    Parents who received vaccination or vaccinated their children in the past or those who were worried about COVID-19 had a higher probability to vaccinate their children

a

Because the study was conducted before the development of a vaccine

b

Calculated respectively on who do not want plan to vaccinate (1025) and who plan to vaccinate (418)

Percentage of vaccine acceptance

The percentage of vaccine acceptance was not so high: only in an Italian study (Barello et al.) 86.1% participants (who were students) chose to be vaccinated against COVID-19. If considering general population, this percentage lessened to a maximum 77.6% (Detoc et al.) people who declared who will probably or certainly accept COVID-19 vaccine. Although all the studies have been conducted in different periods, the percentages did not differ so much.

For influenza vaccine alone, the situation is similar: the maximum percentage of acceptance was reported in the study of Grech et al. (69%), but the only study focused exclusively on influenza vaccine (Goldman et al.) showed that only 54.3% of parents were favorable to vaccinate their children and 58.3% intended to vaccinate themselves.

Influencing factors and reasons given by participants who refused the vaccination

Factors that influenced the choice to accept the vaccines (or not) could be resumed as follows:

  • Ethnicity: black/African had a lower acceptance

  • Working status: unemployed people had a lower acceptance

  • Personal belief: participants with personal belief against vaccines had lower acceptance; those who received vaccinations (especially influenza) in the past had a higher acceptance

  • Religiosity: religiosity was negatively correlated with COVID-19 vaccination

  • Politics (!): Respondents who declared Democratic political partisanship were significantly more likely to choose to receive vaccination (Kreps et al.). Those who felt close to radical parties or those who did not vote/did not feel close to any party were significantly more likely to refuse the vaccine (Ward et al.). Those who voted for far left or far right candidate in the last elections were more likely to refuse vaccination (COCONEL Group). Pogue et al. observed that political ideology had no relationship with the attitude toward vaccination.

  • Gender: Women had a lower acceptance.

  • Education (!): participants with low education had a lower acceptance (except for the study conducted in Turkey by Salali et al.)

  • Age (!): low age was associated to a lower willingness to receive vaccination. Except for the study of Palamenghi et al. who observed that middle age group had a reduced willingness to be vaccinated compared with 18–34-year-old people and people aged more than 60 years. Also the COCONEL group observed a higher hesitancy among older than 75 years.

  • Income (!): participants with lower income had lower acceptance. Pogue et al. observed that income had no relationship with the attitude toward vaccination.

  • COVID-19 infection: no difference observed between those who have been infected and those who have not.

  • Concern about COVID-19: those who were highly concerned about being infected were less likely to refuse the vaccine.

  • Working in healthcare settings (!): healthcare workers had a higher acceptance. Except for the study of Dror et al. who observed no difference in vaccine acceptance among healthcare personnel and not-healthcare personnel. Also Barello et al. observed no significant differences among healthcare students or not.

(!) = this symbol is used to highlight factors with conflicting results.

The most given reasons to refuse vaccine were being against vaccines in general, concerns about safety/thinking that a vaccine produced in a rush is too dangerous, considering the vaccine useless because of the harmless nature of COVID-19, general lack of trust, doubts about the efficiency of the vaccine, belief to be already immunized, doubt about the provenience of vaccine.

Discussion

Our review highlighted an overall high vaccine hesitancy toward the COVID-19 vaccine, but also toward influenza vaccine. These results are not surprising: studies around the world on vaccine hesitancy, in general, showed prevalence ranging from 8% to 15%.27, 28, 29 However, it should be specified that the speed of the pandemic and the considered time span (up to November 2020) could make our results not totally representative of the real situation.

One of the most interesting aspects of the review is the point-to-point analysis of factors that influenced the acceptance or refusal. This represents, however, an instantaneous photography of the actual situation: in fact, as Williams et al. reported, although the reasons why parents chose to delay or refuse vaccines for their children have been thoroughly examined, the reasons for vaccine delay or refusal may change over time.30

In our review black or African people had a lower acceptance rate. This datum is in line with another study that showed that among African Americans, there was a higher degree of skepticism and concern about the flu vaccine.31

Our review highlighted that unemployed people and those with a lower income had a lower acceptance rate; however, Pogue et al. observed that income had no relationship with the attitude toward vaccination. In addition, participants with low education had a lower acceptance rate (except for the study conducted in Turkey by Salali et al.). These data are partially in line with what reported by Danis et al.: their study revealed how economic hardship represented a determinant of vaccine hesitancy, while no association was found between economic hardship and vaccine refusal. On the other hand, the lower education of both mother and father was a valid predictor of refusal of all vaccines, while hesitancy seemed to not be affected by parental education.32

In another survey although caregivers from households in the 3rd or 4th quintiles were more likely to fully immunize their children than those in the other quintiles, this was not statistically significant.33

Our findings showed that a higher level of education seemed to be a protective factor against refusing vaccines. However, there was no consensus about this association in other studies, some being in contrast,34 , 35 in accordance36 or showing no significant association.37 Parents with a higher-education background may use selected sources of information, relying on a critical-thinking attitude and making more active choices.38

In our review, we observed that religiosity was negatively correlated with COVID-19 vaccination. This particular aspect has already been described by other authors which observed that some people avoided vaccination based on religious grounds including religious explanations (“God did not take any medicine”) or associating vaccines with Satanism.39

One of the most interesting aspects of our review is the influence of political ideology on vaccine acceptance or refusal: people who declared Democratic political partisanship were significantly more likely to choose to receive vaccination; those who felt close to radical parties or those who did not vote/did not feel close to any party were significantly more likely to refuse the vaccine; those who voted for far left or far right candidate in the last elections in France were more likely to refuse vaccination. This kind of analysis has already been conducted by Kennedy et al. with a focus on populist party: they observed that the support for populist parties could be used as a proxy for vaccine hesitancy, at least in the Western European context, with an increase in support being a signal for public health actors to be vigilant.40

In our review, we observed that women had a lower acceptance rate. This datum is in line with other studies that found high rates of women expressing concerns about the safety of vaccines and expressing a lack of trust in the quality and impartiality of information provided by healthcare professionals.41

In our review, we observed three apparently independent phenomena: 1) low age was associated to a lower willingness to receive vaccination; 2) those who were highly concerned about being infected were less likely to refuse the vaccine; 3) no difference observed between those who have been infected and those who have not. It is important to remember that risk perception is an important factor influencing risk behaviors and people with lower risk perception tend to take risk behaviors or reduce preventive behaviors.42 Young people (such as college students as reported by Ding et al.) are usually healthy, and often have mild symptoms after being infected with COVID-19, which can have a significant impact on the spread of COVID-19.43 So it is conceivable that they could tend to refuse vaccination because of the scarce perception of the risk so, as suggested by Ding et al., it is necessary to improve the risk perception of college students through health education in various ways, and attention should be paid to some college students with low risk perception.43

Vaccine acceptance from healthcare workers had conflicting results: in general, healthcare workers had a higher acceptance, but in the study of Dror et al. no difference was observed in vaccine acceptance among healthcare personnel and not-healthcare personnel; also Barello et al. observed no significant differences among healthcare students or not. The problem of vaccine hesitancy among healthcare workers has been extensively studied by the European Centre for Disease Control reporting that healthcare workers had concerns relating to the risks of vaccination and expressed a lack of trust in health authorities. Even some healthcare workers were also against vaccination in general.44

The most given reasons to refuse vaccine were as follows: being against vaccines in general, concerns about safety/thinking that a vaccine produced in a rush is too dangerous, considering the vaccine useless because of the harmless nature of COVID-19, general lack of trust, doubts about the efficiency of the vaccine, belief to be already immunized, doubt about the provenience of vaccine.

These evidences are quite in line with what reported in other studies. For example, Pugliese-Garcia et al. reported in their survey the respondents’ fear of being injected incorrectly or contracting infections, of the fear of pain.39 Perceptions of vaccine effectiveness were often grounded in misconceptions about how, for whom and for how long vaccines work. Respondents believed that vaccines worked against illnesses, particularly for childhood illness, rather than being disease-specific.39 Alabbad et al., instead, reported that the most common reason for vaccine refusal was believing that it had no positive effect and that it was unnecessary.28

Krishnamoorthy et al. interviewed parents and health workers, who reported that the major reason for the hesitancy was the rumors spread regarding the safety of the vaccine through social media. They have mentioned that the message was circulated with friends, relatives, and other community domains without confirming the authenticity of the information. However, repeated awareness sessions through various mass media channels have helped to overcome these barriers.45

In some studies, even, some participants preferred informal, traditional, and religious approaches to prevention and cure. Participants described cases of young men using beer, spirits and local alcohol, Tujilijili, Junta, and Kachasu, while others used other informal and traditional alternatives such as traditional brews, herbs, and tattoos.39

Conclusions

Vaccine hesitancy still remains high, also during COVID-19 pandemic, and the reasons for vaccine refusals are several. This phenomenon represents an important problem, because increasing hesitancy leads to falls in coverage and often precedes an infectious disease outbreak.40

Healthcare professionals (especially general practitioners and pediatricians) should be involved to support people and help informed deciding about vaccinations.46 , 47 However, although researchers have begun to develop and evaluate interventions for vaccine-hesitant people (especially parents), the current data do not support one method for intervention as superiorly effective over others; therefore, continued development and evaluation of interventions is needed.30

Author statements

Ethical approval

Ethical approvement is not necessary because it is a review of the literature.

Funding

None declared.

Competing interests

None declared.

References

  • 1.Group, T.S.V.H.W . 2013. What influences vaccine acceptance: a model of determinants of vaccine hesitancy. [Google Scholar]
  • 2.Zhou M.Y., et al. From SARS to COVID-19: what we have learned about children infected with COVID-19. Int J Infect Dis. 2020;96:710–714. doi: 10.1016/j.ijid.2020.04.090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gorbalenya A.E., B S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A. 2020. Severe acute respiratory syndrome-related coronavirus: the species and its viruses – a statement of the Coronavirus Study Group. [Google Scholar]
  • 4.Pascarella G., et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206. doi: 10.1111/joim.13091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dhama K., et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccines Immunother. 2020;16(6):1232–1238. doi: 10.1080/21645515.2020.1735227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.CDC . 2021. Different COVID-19 vaccines.https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html Updated Jan. 15, 2021. 28/01/2021]; Available from. [Google Scholar]
  • 7.Agency, E.M. 2021. Treatments and vaccines for COVID-19: authorised medicines.https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/treatments-vaccines-covid-19-authorised-medicines 19/2/2021]; Available from. [Google Scholar]
  • 8.Grech V., Gauci C., Agius S. Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination. Early Hum Dev. 2020:105213. doi: 10.1016/j.earlhumdev.2020.105213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Strauss R.P., et al. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. J Acquir Immune Defic Syndr. 2001;26(1):63–71. doi: 10.1097/00126334-200101010-00010. [DOI] [PubMed] [Google Scholar]
  • 10.Karafillakis E., et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccines Immunother. 2019;15(7–8):1615–1627. doi: 10.1080/21645515.2018.1564436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Verger P., Dube E. Restoring confidence in vaccines in the COVID-19 era. Expert Rev Vaccines. 2020:1–3. doi: 10.1080/14760584.2020.1825945. [DOI] [PubMed] [Google Scholar]
  • 12.Chou W.S., Budenz A. Considering emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Commun. 2020:1–5. doi: 10.1080/10410236.2020.1838096. [DOI] [PubMed] [Google Scholar]
  • 13.Group C. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20(7):769–770. doi: 10.1016/S1473-3099(20)30426-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Olagoke A.A., Olagoke O.O., Hughes A.M. Intention to vaccinate against the novel 2019 coronavirus disease: the role of health locus of Control and religiosity. J Relig Health. 2020 Oct;30:1–16. doi: 10.1007/s10943-020-01090-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kreps S., et al. Factors associated with US adults' likelihood of accepting COVID-19 vaccination. JAMA Netw Open. 2020;3(10) doi: 10.1001/jamanetworkopen.2020.25594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Salali G.D., Uysal M.S. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2020:1–3. doi: 10.1017/S0033291720004067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ward J.K., et al. The French public's attitudes to a future COVID-19 vaccine: the politicization of a public health issue. Soc Sci Med. 2020;265:113414. doi: 10.1016/j.socscimed.2020.113414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pogue K., et al. Influences on attitudes regarding potential COVID-19 vaccination in the United States. Vaccines. 2020;8(4) doi: 10.3390/vaccines8040582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Graffigna G., et al. Relationship between citizens' health engagement and intention to take the COVID-19 vaccine in Italy: a mediation analysis. Vaccines. 2020;8(4) doi: 10.3390/vaccines8040576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Detoc M., et al. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002–7006. doi: 10.1016/j.vaccine.2020.09.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wang K., et al. Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: a cross-sectional survey. Vaccine. 2020;38(45):7049–7056. doi: 10.1016/j.vaccine.2020.09.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fisher K.A., et al. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. Adults. Ann Intern Med. 2020 Dec;173(12):964–973. doi: 10.7326/M20-3569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Palamenghi L., et al. Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. Eur J Epidemiol. 2020;35(8):785–788. doi: 10.1007/s10654-020-00675-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Dror A.A., et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–779. doi: 10.1007/s10654-020-00671-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Goldman R.D., et al. Willingness to vaccinate children against influenza after the coronavirus disease 2019 pandemic. J Pediatr. 2020 Jan;228:87–93. doi: 10.1016/j.jpeds.2020.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Barello S., et al. 'Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic. Eur J Epidemiol. 2020;35(8):781–783. doi: 10.1007/s10654-020-00670-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Giambi C., et al. Parental vaccine hesitancy in Italy - results from a national survey. Vaccine. 2018;36(6):779–787. doi: 10.1016/j.vaccine.2017.12.074. [DOI] [PubMed] [Google Scholar]
  • 28.Alabbad A.A., et al. Prevalence of influenza vaccine hesitancy at a tertiary care hospital in Riyadh, Saudi Arabia. J Infect Public Health. 2018;11(4):491–499. doi: 10.1016/j.jiph.2017.09.002. [DOI] [PubMed] [Google Scholar]
  • 29.Cunningham R.M., et al. Prevalence of vaccine hesitancy among expectant mothers in Houston, Texas. Acad Pediatr. 2018;18(2):154–160. doi: 10.1016/j.acap.2017.08.003. [DOI] [PubMed] [Google Scholar]
  • 30.Williams S.E. What are the factors that contribute to parental vaccine-hesitancy and what can we do about it? Hum Vaccines Immunother. 2014;10(9):2584–2596. doi: 10.4161/hv.28596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Quinn S.C., et al. Exploring racial influences on flu vaccine attitudes and behavior: results of a national survey of White and African American adults. Vaccine. 2017;35(8):1167–1174. doi: 10.1016/j.vaccine.2016.12.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Danis K., et al. Socioeconomic factors play a more important role in childhood vaccination coverage than parental perceptions: a cross-sectional study in Greece. Vaccine. 2010;28(7):1861–1869. doi: 10.1016/j.vaccine.2009.11.078. [DOI] [PubMed] [Google Scholar]
  • 33.Akwataghibe Ngozi N., O E.A., Broerse Jacqueline E.W., Popoola Oluwafemi A., Agbo Adanna I., Dieleman Marjolein A. Exploring factors influencing immunization utilization in Nigeria—a mixed methods study. Front Public Health. 2019;7:392. doi: 10.3389/fpubh.2019.00392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Anello P., et al. Socioeconomic factors influencing childhood vaccination in two northern Italian regions. Vaccine. 2017;35(36):4673–4680. doi: 10.1016/j.vaccine.2017.07.058. [DOI] [PubMed] [Google Scholar]
  • 35.Hak E., et al. Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program. Vaccine. 2005;23(24):3103–3107. doi: 10.1016/j.vaccine.2005.01.074. [DOI] [PubMed] [Google Scholar]
  • 36.Bocquier A., et al. Socioeconomic differences in childhood vaccination in developed countries: a systematic review of quantitative studies. Expert Rev Vaccines. 2017;16(11):1107–1118. doi: 10.1080/14760584.2017.1381020. [DOI] [PubMed] [Google Scholar]
  • 37.Arat A., et al. Social inequities in vaccination coverage among infants and pre-school children in Europe and Australia - a systematic review. BMC Publ Health. 2019;19(1):290. doi: 10.1186/s12889-019-6597-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Feiring B., et al. Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway. BMJ Open. 2015;5(5) doi: 10.1136/bmjopen-2014-006422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Pugliese-Garcia M., et al. Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia. Vaccine. 2018;36(37):5617–5624. doi: 10.1016/j.vaccine.2018.07.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kennedy J. Populist politics and vaccine hesitancy in Western Europe: an analysis of national-level data. Eur J Publ Health. 2019;29(3):512–516. doi: 10.1093/eurpub/ckz004. [DOI] [PubMed] [Google Scholar]
  • 41.Rosso A., et al. Factors affecting the vaccination choices of pregnant women for their children: a systematic review of the literature. Hum Vaccines Immunother. 2020;16(8):1969–1980. doi: 10.1080/21645515.2019.1698901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Adefuye A.S., et al. HIV sexual risk behaviors and perception of risk among college students: implications for planning interventions. BMC Publ Health. 2009;9:281. doi: 10.1186/1471-2458-9-281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ding Y., et al. Risk perception of coronavirus disease 2019 (COVID-19) and its related factors among college students in China during quarantine. PloS One. 2020;15(8) doi: 10.1371/journal.pone.0237626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.ECDC . 2015. Vaccine hesitancy among healthcare workers and their patients in Europe. [Google Scholar]
  • 45.Krishnamoorthy Y., et al. Factors related to vaccine hesitancy during the implementation of Measles-Rubella campaign 2017 in rural Puducherry-A mixed-method study. J Fam Med Prim Care. 2019;8(12):3962–3970. doi: 10.4103/jfmpc.jfmpc_790_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Danchin M.H., et al. Vaccine decision-making begins in pregnancy: correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake. Vaccine. 2018;36(44):6473–6479. doi: 10.1016/j.vaccine.2017.08.003. [DOI] [PubMed] [Google Scholar]
  • 47.Bechini A., et al. Impact assessment of an education course on vaccinations in a population of pregnant women: a pilot study. J Prev Med Hyg. 2019;60(1):E5–E11. doi: 10.15167/2421-4248/jpmh2019.60.1.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Public Health are provided here courtesy of Elsevier

RESOURCES